Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2026-06-10 15:09:20 ET · period of report 2026-06-08 · accession 0001961994-26-000021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-10 15:09 | 2026-06-08 | EBS | Williams Paul Anthony | SVP, Products Business | F - Tax | $8.00 | -694 | 162.1K | -0.4% | -$5,552 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-08 | F | D | 694 | $8.00 | 162,098 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes associated with vesting and settlement of restricted stock units. |